drug

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced that it has completed its trial entitled “A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple…

Editors note: This partnership article is part of a “PR Pack” reward by EU-Startups, Enterie PR network and Profeina PR agency. EIT Jumpstarter, a leading pre-acceleration program by the European…